Global Sexually Transmitted Disease (STD) Diagnostics Market to Reach US$ 135.94 Billion by 2028, Propelled by Development of Multiplex Assays

May 23, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Sexually Transmitted Disease (STD) Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global sexually transmitted disease (STD) diagnostics market size reached US$ 98.71 Billion in 2022. Sexually transmitted disease (STD) diagnostics refers to scientific tools and techniques used to identify, detect, and confirm the presence of STDs in an individual. It includes polymerase chain reaction (PCR) tests, nucleic acid amplification tests (NAATs), enzyme-linked immunosorbent assays (ELISAs), point-of-care (PoC) devices, and self-testing kits. STD diagnostics utilize blood, urine, genital swab, and fluid samples to detect the presence of pathogens and markers related to STDs. It is widely used to diagnose chlamydia, syphilis, gonorrhea, herpes, hepatitis B and C, human immunodeficiency virus (HIV), and human papillomavirus (HPV). STD diagnostics are highly efficient and accurate techniques that aid in the early detection of infections, enable timely intervention, prevent future complications, and increase patient outcomes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:

The rising prevalence of STDs due to unprotected sexual intercourse and drug abuse is one of the key factors propelling the market growth. STD diagnostics are widely used to determine the severity of infections, prevent further transmission, and identify potential treatment options to improve patient outcomes. Furthermore, the growing awareness among the masses regarding early disease detection to avoid various future complications, such as cancer, congenital disabilities, and infertility, is acting as another growth-inducing factor. Additionally, the recent development of multiplex assays, which allows simultaneous detection of multiple STD pathogens in a single test, thus, reducing costs, saving time, and improving diagnostic accuracy, is positively influencing the market growth. Besides this, the introduction of self-testing kits that allow individuals to conveniently test the presence of STDs in their homes without visiting healthcare facilities, which aids in improving accessibility, enhancing patient comfort, and maintaining privacy, is providing an impetus to the market growth. Apart from this, the implementation of supportive government policies to educate the masses about STDs, promote early detection, and provide access to high-quality treatment and testing facilities is contributing to the market growth. Other factors, including rising healthcare expenditure, increasing investment in the development of advanced diagnostic tools, and growing emphasis on sexual health among the masses, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 135.94 Billion by 2028, exhibiting a CAGR of 5.39% during 2023-2028.

Market Summary:

  • On the basis of the type, the market has been divided into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, chancroid testing, and others. Among these, chlamydia testing represents the largest segment.
  • Based on the device type, the market has been classified into laboratory devices (thermal cycler – PCR, lateral flow readers, flow cytometers, absorbance microplate reader – enzyme linked immunosorbent assay (ELISA), and others) and point of care (PoC) devices (phone chips (microfluidic + ICT) and portable/bench top/rapid diagnostic kits). At present, laboratory devices accounts for the largest market share.
  • On the basis of end user, the market has been divided into laboratory and point of care (PoC) testing. Among these, laboratory testing represents for the largest market share.
  • On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. At present, North America holds the largest market share.
  • The competitive landscape of the industry has also been examined, with some of the key players being Abbott Laboratories, Becton Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc.

Report Scope:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Types Covered Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Others
Device Types Covered Laboratory Devices - Thermal Cycler – PCR,
Lateral Flow Readers, Flow Cytometers,
Absorbance Microplate Reader – Enzyme Linked Immunosorbent Assay (ELISA), Others
Point of Care (PoC) Devices - Phone Chips (Microfluidics + ICT), Portable/Bench Top/Rapid Diagnostic Kits
End Users Covered Laboratory Testing, Point of Care (PoC) Testing
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Sexually Transmitted Disease (STD) Diagnostics Market to Reach US$ 135.94 Billion by 2028, Propelled by Development of Multiplex Assays
Purchase options Year End sale

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More